(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.27%) $79.16
(0.05%) $2.04
(0.18%) $2 313.70
(0.36%) $26.93
(0.06%) $963.20
(-0.13%) $0.932
(-0.44%) $10.98
(-0.12%) $0.798
(-2.29%) $91.12
0.00% $ 13.85
Live Chart Being Loaded With Signals
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States...
Stats | |
---|---|
Tagesvolumen | 1 072.00 |
Durchschnittsvolumen | 1 198.00 |
Marktkapitalisierung | 16.11M |
EPS | $0 ( 2023-03-30 ) |
Last Dividend | $0.103 ( 2023-08-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | -26.13 |
ATR14 | $0 (0.00%) |
BIG PHARMA SPLIT CORP Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
BIG PHARMA SPLIT CORP Finanzdaten
Annual | 2023 |
Umsatz: | $311 764 |
Bruttogewinn: | $311 764 (100.00 %) |
EPS: | $-0.110 |
FY | 2023 |
Umsatz: | $311 764 |
Bruttogewinn: | $311 764 (100.00 %) |
EPS: | $-0.110 |
FY | 2022 |
Umsatz: | $3.71M |
Bruttogewinn: | $3.71M (100.00 %) |
EPS: | $1.580 |
FY | 2021 |
Umsatz: | $5.36M |
Bruttogewinn: | $0.00 (0.00 %) |
EPS: | $3.27 |
Financial Reports:
No articles found.
BIG PHARMA SPLIT CORP Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.309 (N/A) |
$0.309 (N/A) |
$0.309 (N/A) |
$0.309 (N/A) |
$0.206 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.103 | 2017-12-28 |
Last Dividend | $0.103 | 2023-08-30 |
Next Dividend | $0 | N/A |
Payout Date | 2023-09-08 | |
Next Payout Date | N/A | |
# dividends | 71 | -- |
Total Paid Out | $7.93 | -- |
Avg. Dividend % Per Year | 5.77% | -- |
Score | 5.84 | -- |
Div. Sustainability Score | 3.49 | |
Div.Growth Potential Score | 1.985 | |
Div. Directional Score | 2.74 | -- |
Year | Amount | Yield |
---|---|---|
2017 | $0 | 0.00% |
2018 | $1.236 | 8.91% |
2019 | $1.236 | 9.94% |
2020 | $1.339 | 9.72% |
2021 | $1.952 | 14.30% |
2022 | $1.236 | 8.55% |
2023 | $0.824 | 5.65% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ZWE.TO | Dividend Knight | 2023-08-29 | Monthly | 10 | 3.81% | |
TRP.TO | Dividend King | 2023-09-28 | Quarterly | 30 | 3.81% | |
MEU.TO | Dividend Junior | 2023-09-18 | Quarterly | 8 | 1.45% | |
CTC-A.TO | Dividend King | 2023-10-30 | Quarterly | 37 | 2.17% | |
XRE.TO | Dividend Knight | 2023-08-25 | Monthly | 23 | 2.24% | |
RCH.TO | Dividend King | 2023-07-19 | Quarterly | 23 | 0.76% | |
GBT.TO | Dividend Knight | 2023-06-22 | Semi-Annually | 29 | 1.36% | |
AQN.TO | Dividend King | 2023-09-27 | Quarterly | 22 | 3.13% | |
VGV.TO | Dividend Knight | 2023-08-31 | Monthly | 7 | 1.42% | |
NA-PE.TO | Dividend Knight | 2023-10-05 | Quarterly | 7 | 3.28% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -2.01 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.0243 | 1.200 | -0.811 | -0.973 | [0 - 0.3] |
returnOnEquityTTM | -0.0387 | 1.500 | -1.542 | -2.31 | [0.1 - 1] |
payoutRatioTTM | -3.27 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.131 | 0.800 | 9.34 | 7.48 | [1 - 3] |
quickRatioTTM | 1.131 | 0.800 | 8.05 | 6.44 | [0.8 - 2.5] |
cashRatioTTM | 0.821 | 1.500 | 6.55 | 9.82 | [0.2 - 2] |
debtRatioTTM | 0.388 | -1.500 | 3.53 | -5.30 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.00 | 2.00 | 6.67 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.00 | 2.00 | 5.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.650 | -1.500 | 7.40 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.132 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.152 | 1.000 | 4.71 | 4.71 | [0.2 - 2] |
assetTurnoverTTM | 0.0121 | 0.800 | -3.25 | -2.60 | [0.5 - 2] |
Total Score | 3.49 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.45 | 1.000 | -2.67 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0387 | 2.50 | -0.991 | -2.31 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.00 | 2.00 | 6.67 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 9.46 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.00 | 2.00 | 6.67 | 10.00 | [0 - 30] |
payoutRatioTTM | -3.27 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 36.96 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 1.985 |
BIG PHARMA SPLIT CORP
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.